Skip to main content

Advertisement

Log in

Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Tuberculin reactions in patients with immunocompromised conditions have been reported to be attenuated compared with healthy controls. In the case of rheumatoid arthritis (RA), several studies have reported conflicting results. We performed this study to evaluate the tuberculin reaction in patients with RA in a region with intermediate burden of tuberculosis. Eighty-one RA patients and 104 age- and sex-matched controls who underwent tuberculin skin test (TST) at Severance Hospital in Seoul, South Korea were reviewed. TST was carried out using the Mantoux method. Indurations larger than 10 mm were considered positive. Information about risk factors for latent tuberculosis infection was acquired. The mean age of the patients with RA was 48 ± 14 years, and the median disease duration was 9 (1–203) months. The mean DAS28 was 5.22 ± 0.13. The control group consisted of healthy living donors for liver transplantation and the patients with diseases not related with immunosuppression. BCG vaccination, close contact history with active tuberculosis, and history of pulmonary tuberculosis were not different between the two groups. The positive rate of TST (34.6% vs. 38.5%) and the median skin induration size (5 mm vs. 6 mm) of the two groups were similar. Medications and DAS28 were not associated with the TST result. The tuberculin reaction of patients with RA is not attenuated compared with that of controls in South Korea.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149:177–184

    PubMed  Google Scholar 

  2. Richeldi L, Losi M, D’Amico R, Luppi M, Ferrari A, Mussini C et al (2009) Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136:198–204

    Article  PubMed  Google Scholar 

  3. Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL et al (2005) The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 20:2720–2724

    Article  PubMed  Google Scholar 

  4. Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360–1361

    Article  PubMed  CAS  Google Scholar 

  5. Wolfe F, Michaud K, Anderson J, Urbansky K (2004) Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50:372–379

    Article  PubMed  CAS  Google Scholar 

  6. Greenberg JD, Reddy SM, Schloss SG, Kurucz OS, Bartlett SJ, Abramson SB et al (2008) Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J Rheumatol 35:770–775

    PubMed  Google Scholar 

  7. Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34:706–711

    PubMed  CAS  Google Scholar 

  8. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC (1998) The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 2:27–36

    PubMed  CAS  Google Scholar 

  9. Helliwell MG, Panayi GS, Unger A (1984) Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy. Clin Rheumatol 3:39–45

    Article  PubMed  CAS  Google Scholar 

  10. Emery P, Panayi GS, Nouri AM (1984) Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis. Clin Exp Immunol 57:123–129

    PubMed  CAS  Google Scholar 

  11. Martinez-Marcos FJ, Lopez-Cortes LF, Pachon J, Alarcon A, Cordero E, Viciana P (1998) Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection. Clin Infect Dis 26:1330–1334

    Article  PubMed  CAS  Google Scholar 

  12. Murakami S, Takeno M, Kirino Y, Kobayashi M, Watanabe R, Kudo M et al (2009) Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis (Edinb) 89:136–141

    Article  CAS  Google Scholar 

  13. Schatz P, Patterson R, Kloner R, Falk J (1976) The prevalence of tuberculosis and positive tuberculin skin test in a steroid-treated asthmatic population. Ann Intern Med 84:261–265

    PubMed  CAS  Google Scholar 

  14. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57:804–809

    Article  PubMed  CAS  Google Scholar 

  15. Neuenschwander BE, Zwahlen M, Kim SJ, Lee EG, Rieder HL (2002) Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guerin in South Korea. Am J Epidemiol 155:654–663

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Beom Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, KH., Jung, SY., Ha, YJ. et al. Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis. Rheumatol Int 32, 1421–1424 (2012). https://doi.org/10.1007/s00296-011-1889-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1889-8

Keywords

Navigation